Additionally, FGF4, a well-known ligand of FGFR2, has been shown to stimulate EMT during cancer progression by increasing store-operated calcium entry (SOCE) and the expression of the calcium signal-associated protein Orai1. The gene discussed is FGFR2; the disease is cancer.